| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/09/1994 | CA2150025A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | CA2149025A1 Humanized antibodies reactive with l-selectin |
| 06/08/1994 | EP0600782A1 C-11 modified pradimicin derivatives |
| 06/08/1994 | EP0600326A2 Antigen peptide of streptolysin O and method of determination of streptolysin antibody |
| 06/08/1994 | EP0600026A1 Cardiac output probe assembly |
| 06/08/1994 | EP0599983A1 Anti-hiv (aids) agents |
| 06/08/1994 | EP0599881A1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 06/08/1994 | EP0495953B1 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo[7.2.0.0(3,8)]undec-2-ene-2-carboxylic acid esters and a process for preparing thereof |
| 06/08/1994 | EP0495896B1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means |
| 06/08/1994 | EP0438554B1 Nitrogenous ambruticines, process for obtaining them and their use |
| 06/08/1994 | EP0366713B1 Esters of 13-trans-retinoic acid |
| 06/08/1994 | EP0362209B1 New synthetic bioactive compounds and method of producing bioactive effect |
| 06/08/1994 | CN1087634A 7-Isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 06/08/1994 | CN1087626A Novel 7-(substituted)-8-(substituted-9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 06/07/1994 | US5319140 Intermediates for cephalosporins with sulfur containing oxyimino side chain |
| 06/07/1994 | US5319103 Intermediate diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-carboxylic acids |
| 06/07/1994 | US5319080 Antiviral agents |
| 06/07/1994 | US5318983 Trisubstituted pyrrole derivatives having antifungine activity, and related pharmaceutical compositions |
| 06/07/1994 | US5318963 Treating respiratory and urinary tract infections caused by gramnegative bacteria |
| 06/07/1994 | CA1330042C Medicinal compositions based on brewers' grains extract, a process for the preparation thereof, and the use of brewers' grains extract for the preparation of cosmetic compositions, and a special brewers' grains extract |
| 06/01/1994 | EP0599512A1 Crystalline carbapenem derivative |
| 06/01/1994 | EP0599188A1 Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity |
| 06/01/1994 | EP0598906A1 Furylthiazole and their use as h 2?-receptor antagonism and antimicrobial |
| 06/01/1994 | EP0598818A1 Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598813A1 Immunostimulation |
| 06/01/1994 | EP0598719A1 Receptor conjugates for targeting drugs and other agents |
| 06/01/1994 | EP0577646A4 Sustained release drug delivery devices |
| 06/01/1994 | CN1087347A Novel sulfonamide inhibitors of aspartyl protease |
| 06/01/1994 | CN1087278A New use of lysozyme dimer and compositions containing the same |
| 06/01/1994 | CN1024796C Process for preparing bicyclic peroxide |
| 06/01/1994 | CN1024754C Antibacterial lyophilized prepn. |
| 05/31/1994 | US5317099 Multistage reaction of triphenylphosphine and chlorocarbons and organic acids and aminocephalosporins for antibiotics |
| 05/31/1994 | US5317095 Alpha-D-glycosyl kasugamycin, its preparation, and antibacterial agent containing the same |
| 05/31/1994 | US5317084 Process for large-scale production of antimicrobal peptide in high purity |
| 05/31/1994 | US5317025 Piperidinylthioindole derivatives, their methods of preparation and pharmaceutical compositions in which they are present, useful especially as analgesics |
| 05/31/1994 | US5317016 Pyrrolidylthiocarbapenem derivative |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316764 Immunization of dogs to form antibodies |
| 05/31/1994 | CA2110147A1 Method for treating systemic inflammatory response syndrome |
| 05/31/1994 | CA2109764A1 C-11 modified pradimicin derivatives |
| 05/26/1994 | WO1994011370A1 Substituted amino alkyl compounds |
| 05/26/1994 | WO1994011361A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011024A1 Composition protective against p. multocida pasteurellosis infection |
| 05/26/1994 | WO1994011010A2 Compositions of oak bark extract, related synthetic compositions, and method of using same |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994011006A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | WO1994008002A3 Methods and compositions for controlling translation of hcv proteins |
| 05/26/1994 | WO1993025543A3 Enniatines and enniatine derivates used to control endoparasites |
| 05/26/1994 | DE4239150A1 O-acyl-4-phenyl-cyclohexanol derivs. - are inhibitors of 2,3-epoxy:squalene-lanosterol cyclase and useful as anti-hypercholesterolaemic for treating atherosclerosis |
| 05/26/1994 | CA2149116A1 Compositions for the regulation of cytokine activity |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2148829A1 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
| 05/25/1994 | EP0598375A2 5-Thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo analogs of beta-lactam, processesfor the preparation thereof and the use thereof |
| 05/25/1994 | EP0598089A1 Novel fluorinated quinolones, process for their preparation and pharmaceutical preparations containing same |
| 05/25/1994 | EP0597852A1 Swine pneumonia vaccine and method for the preparation thereof |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 05/25/1994 | EP0559768B1 Oral spiramycine formulations and method for preparing same |
| 05/25/1994 | CN1087089A Therapeutic nucleosides |
| 05/25/1994 | CN1087088A Ni-substituted 1H-1,2,3-triazdo|4,5-d¨ pyrimidine, preparing of same and application as antivirus pharmaceutical |
| 05/25/1994 | CN1024669C Cephem compound and process for preparation thereof |
| 05/25/1994 | CN1024668C Process for preparing 2-(2-isoxazolyl)-2-tetrahydrofuran carboxylic acid derivatives |
| 05/24/1994 | US5315012 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds |
| 05/24/1994 | US5314999 Fungicides, amphoteracin derivatives |
| 05/24/1994 | US5314917 Method for inactivating enveloped viruses and sperm |
| 05/24/1994 | US5314911 Antitumor, fungicide |
| 05/24/1994 | US5314905 Antitumor |
| 05/24/1994 | US5314904 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
| 05/24/1994 | US5314893 Antiviral tetrahydropyrans |
| 05/24/1994 | US5314881 Wound healing |
| 05/24/1994 | US5314878 Composition for removing or inactivating harmful components in blood or other extracellular body fluids |
| 05/24/1994 | US5314689 Acyl-carnitine for the treatment and prevention of viral infections |
| 05/24/1994 | CA2109537A1 Trans and cis traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity |
| 05/18/1994 | EP0597429A2 Process for the production of 3-vinylcephalosporins |
| 05/18/1994 | EP0597423A2 Azetidinone compound and process for preparation thereof |
| 05/18/1994 | EP0597303A2 Cephalosporin derivatives |
| 05/18/1994 | EP0597049A1 Antifungal agents |
| 05/18/1994 | EP0597016A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 05/18/1994 | EP0597003A1 Quinoline derivatives as immunostimulants |
| 05/18/1994 | EP0596962A1 Therapeutic compositions and methods |
| 05/18/1994 | EP0596935A1 Antiviral pharmaceutical compositions for vaginal administration. |
| 05/18/1994 | EP0596917A1 Benzimidazole anthelmintics |
| 05/18/1994 | EP0555210A4 Microbiocidal combinations of materials and their use |
| 05/18/1994 | EP0463043B1 Method for stabilizing the hybridization of complementary polynucleotide sequences |
| 05/18/1994 | CN1086809A 5-OXO-dibenzo (a,d) cyclohepta-1, 4-dienes |
| 05/18/1994 | CN1024554C Antibacterial-2 carbapenem derivatives preparation method |
| 05/17/1994 | US5312837 Method of treating viral infections with aryl macrocyclic compounds |
| 05/17/1994 | US5312831 Immunology, anticarcinogenic agents and AIDS treatment |
| 05/17/1994 | US5312823 7-azaisoindolinyl-quinolone-carboxylic acid derivatives |
| 05/17/1994 | US5312815 Fungicidal (+)-2-(2,4-difluorophenyl)-3-methyl-1-(1H-1,2,4-triazol-1-yl)3-(6-(1H-1,2,4-triazol-1-yl)pyridazin-3-ylthio) butan-2-ol |
| 05/17/1994 | US5312814 α-phosphonocarboxylate squalene synthetase inhibitors |
| 05/17/1994 | US5312738 Vancomycins |
| 05/17/1994 | CA1329621C Naphthoquinones in the treatment or prophylaxis of pneumocystis carinii infections |
| 05/17/1994 | CA1329616C Aromatase inhibiting 4(5)-imidazoles |
| 05/13/1994 | CA2108609A1 Cephalosporin derivatives |
| 05/11/1994 | WO1994010317A2 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010301A1 TNF-α RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |